Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Linaclotide: a new option for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation in adults.

Clinical medicine insights. Gastroenterology·2014
Same journal

Evaluation of funding gastroenterology research in Canada illustrates the beneficial role of partnerships.

Canadian journal of gastroenterology = Journal canadien de gastroenterologie·2013
Same journal

Use of fecal occult blood test in hospitalized patients: survey of physicians practicing in a large central Canadian health region and Canadian gastroenterologists.

Canadian journal of gastroenterology = Journal canadien de gastroenterologie·2013
Same journal

Treatment of chronic hepatitis C in a Canadian Aboriginal population: results from the PRAIRIE study.

Canadian journal of gastroenterology = Journal canadien de gastroenterologie·2013
Same journal

A randomized controlled trial comparing sequential with triple therapy for Helicobacter pylori in an Aboriginal community in the Canadian North.

Canadian journal of gastroenterology = Journal canadien de gastroenterologie·2013
Same journal

Improving the quality of colonoscopy bowel preparation using an educational video.

Canadian journal of gastroenterology = Journal canadien de gastroenterologie·2013
Same journal

Putting an end to the misuse of the fecal occult blood test in diagnostic medicine.

Canadian journal of gastroenterology = Journal canadien de gastroenterologie·2013
See all related articles

Related Experiment Video

Updated: May 27, 2026

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
03:50

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease

Published on: August 18, 2023

Chronic constipation: current treatment options.

Louis Wing Cheong Liu1

  • 1Department of Medicine, University of Toronto, Toromto, Canada. louis.liu@uhn.on.ca

Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|November 25, 2011
PubMed
Summary
This summary is machine-generated.

This review updates chronic constipation management guidelines. It highlights prucalopride

Related Experiment Videos

Last Updated: May 27, 2026

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
03:50

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease

Published on: August 18, 2023

Area of Science:

  • Gastroenterology
  • Pharmacology
  • Evidence-based Medicine

Background:

  • Constipation is a prevalent functional gastrointestinal disorder impacting all age groups.
  • Previous Canadian guidelines for chronic constipation management were established in 2007.
  • Tegaserod is no longer available in Canada, necessitating updated recommendations.

Purpose of the Study:

  • To summarize existing recommendations for chronic constipation management.
  • To review new evidence on various treatment modalities.
  • To propose an updated management pyramid for chronic constipation in Canada.

Main Methods:

  • Review of published literature on constipation management.
  • Inclusion of data from randomized, placebo-controlled trials.
  • Application of the Grading of Recommendations, Assessment, Development and Evidence (GRADE) system.

Main Results:

  • Prucalopride, a selective serotonin receptor agonist, demonstrates efficacy and safety.
  • Evidence supports the use of stimulant laxatives, polyethylene glycol, and probiotics.
  • New data on lubiprostone and linaclotide are also presented.

Conclusions:

  • An updated management pyramid for chronic constipation is proposed.
  • Recommendations consider evidence quality, treatment impact, and Canadian availability.
  • The review provides a comprehensive overview of current constipation management strategies.